Ercogroup is a manufacturer and part of a group of companies. They develop products and materials for dental implants, conduct laboratory testing involving animals, own a training center and a clinical facility for the development of technologies and product guidelines, manufacturing and distribution of their own products and products of other world brands.
हम अपने ग्राहकों के लिए सरल और उन्नत उत्पाद लाने के लिए तकनीकी परिवर्तन लाते हैं।
विनिर्माण
आविष्कार
Designed for single and short bridges fabricated at the implant level…
इम्प्लांट स्तर पर निर्मित एकल क्राउन और छोटे पुलों के लिए डिज़ाइन किया गया।
विनिर्माण
आविष्कार
In-house production of drills for surgical and navigation kits allows us to maintain high quality standards and ensure prompt order fulfillment…
सर्जिकल और नेविगेशन किट के लिए ड्रिल का इन-हाउस उत्पादन हमें उच्च गुणवत्ता मानकों को बनाए रखने और त्वरित ऑर्डर पूर्ति सुनिश्चित करने की अनुमति देता है। सभी ड्रिल ग्रेनाइट-आधारित मशीन पर निर्मित होते हैं, जो अधिकतम तीक्ष्णता और परिशुद्धता सुनिश्चित करता है।
विनिर्माण
आविष्कार
Designed for a full bridge prosthesis supported by four or more implants. Angled abutments provide a solution for a prosthetic challenge in case of diverging or tilted implants…
4 या अधिक इम्प्लांट द्वारा समर्थित एक पूर्ण पुल के लिए डिज़ाइन किया गया।
तिरछे एबटमेंट अलग-अलग या झुके हुए इम्प्लांट के मामले में एक कृत्रिम चुनौती के लिए एक समाधान प्रदान करते हैं।
The matrix is produced of bovine bone. During a multi-stage controlled cleaning process, native xenogeneic bone tissue is purified from proteins and other components that could cause adverse immunological and inflammatory reactions when implemented into the patient organism. Specific treatment increases the material’s regenerative effect.
The used xenogenic bone material possesses the required quality certificates from the manufacturer and it also undergoes additional veterinary and sanitary control. Raw material sampling is performed in compliance with the international standard ISO 22442, "Medical devices utilizing animal tissues and their derivatives". By avoiding the use of allografts, the transmission of any infections and diseases is minimized. Our unique purification technology ensures a bacteria- and virus-free final product, which actively promotes rapid bone formation. This accelerated regeneration of strong, native bone prevents the common complication where an imbalance between graft resorption and new bone formation leads to the filling of voids with soft fibrous tissue instead of bone. Furthermore, the technology removes all immunogenic components from the bone material while preserving the native tissue's biological and mechanical integrity.
Our exclusive technology endows all REGEGRAFT® osteoplastic materials with inherent osteoinductivity — the unique ability to induce and accelerate the growth of new bone tissue.
Thank you for your interest in our products! To apply, please provide the requested information. By submitting this form, you confirm that you have reviewed and understand the relevant product details.
